This Directive lays down standards of quality and safety of human blood and of blood components, in order to ensure a high level of human health protection.
Art. 1 Directive (EU) 2002/98
Objectives
Judgment of the Court (First Chamber), 13 March 2014. Octapharma France SAS v Agence nationale de sécurité du médicament et des produits de Decision
Article 1 of Directive 2002/98 provides: ‘This Directive lays down standards of quality and safety of human blood and of blood components, in order to ensure a high level of human health protection.’
13 Mar 2014 · 62012CJ0512
Judgment of the Court (Eighth Chamber) of 10 March 2021. Ordine Nazionale dei Biologi and Others v Presidenza del Consiglio dei Ministri.Decision
In that regard, it must be noted that Directive 2002/98, the objective of which is the protection of public health, is based on Article 168 TFEU, paragraph 1 of which provides that a high level of human health protection is to be ensured …
10 Mar 2021 · 62020CJ0096
Opinion of Advocate General Mengozzi delivered on 17 July 2014. Geoffrey Léger v Ministre des Affaires sociales, de la Santé et des Droits dDecision
Adopted on the basis of Article 152(4)(a) EC [now Article 168(4)(a) TFEU], Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, …
17 Jul 2014 · 62013CC0528
Opinion of Advocate General Jääskinen delivered on 7 November 2013. Octapharma France SAS v Agence nationale de sécurité du médicament et deDecision
Further, Directive 2002/98 introduced several provisions aimed at laying down standards of quality and safety of human blood and of blood components, in order to ensure a high level of human health protection (see Article 1).
7 Nov 2013 · 62012CC0512
Changed on 7 Aug 2009
Objectives
- 7 Aug 2009 – todayin force
- 27 Jan 2003 – 7 Aug 2009earlier wording
Versions are held from 27 Jan 2003; the article may be older.